-

report

PDUFA VII PhRMA Priorities

PDUFA VII PhRMA Priorities Letter

PhRMA and our member companies support a strong and science-based U.S. FDA staffed appropriately and resourced through a combination of appropriated funds and user fees from the regulated industry. For nearly 30 years, PDUFA has helped the FDA fulfill its central mission – to help protect and promote the public health – by allowing the Agency to keep pace with the rapid increase in the number and complexity of innovative drugs and biologics entering the review pipeline.